Senti Biosciences, Inc.
SNTI
$2.08
-$0.02-0.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.03% | -4.40% | -2,213.44% | 97.89% | -157.66% |
| Total Depreciation and Amortization | -1.09% | -1.30% | -36.53% | 54.23% | -2.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.89% | 29.98% | 109.34% | -178.28% | 1,699.22% |
| Change in Net Operating Assets | 860.07% | 60.40% | -41.74% | -140.73% | 22.80% |
| Cash from Operations | 27.74% | 6.95% | -4.04% | -71.68% | 5.74% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -118.33% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -74.53% | -- | -- | 490,390.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.52% | 215.22% | -118.47% | -7.78% | -- |
| Cash from Financing | -87.73% | 344.20% | -100.81% | 2,002.05% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.88% | 15.33% | -138.29% | 803.97% | 35.70% |